|
Index of reports
> Cases with Neutropenia (217)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Carboplatin where reactions include neutropenia. The selected reports were submitted to the FDA during the sample period of about a year. Reports 1 - 30 of 217 Next >>
Possible Carboplatin side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-27
Patient:
Reactions: Off Label Use, Gastrointestinal Toxicity, Neutropenia, Infection
Drug(s) suspected as cause:
Carboplatin
Dosage: 6 courses in high risk
Indication: Retinoblastoma
Cyclophosphamide
Indication: Retinoblastoma
Doxorubicin Hydrochloride
Dosage: 4 courses in intermediate risk and 6 courses in high risk
Indication: Retinoblastoma
Etoposide
Indication: Retinoblastoma
Vincristine
Dosage: 4 courses in intermediate risk and 6 courses in high risk
Indication: Retinoblastoma
Other drugs received by patient: Neupogen
Possible Carboplatin side effects in female
Reported by a physician from Ireland on 2012-08-24
Patient: female, weighing 75.5 kg (166.1 pounds)
Reactions: Vomiting, Diarrhoea, Neutropenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Carboplatin
Dosage: 790mg cyclic
Indication: Breast Cancer
Start date: 2012-08-09
Docetaxel
Dosage: 75mgm2 cyclic
Indication: Breast Cancer
Start date: 2012-08-09
Lapatinib
Dosage: 1000mg per day
Administration route: Oral
Indication: Breast Cancer
Start date: 2012-08-09
Trastuzumab
Dosage: 8mgk cyclic
Indication: Breast Cancer
Start date: 2012-08-09
Possible Carboplatin side effects in 65 year old female
Reported by a physician from Japan on 2012-08-24
Patient: 65 year old female, weighing 50.2 kg (110.6 pounds)
Reactions: Weight Decreased, Blood Bilirubin Increased, Cytomegalovirus Viraemia, Headache, Pyrexia, Interstitial Lung Disease, Oedema, Thrombocytopenia, Blood Sodium Decreased, Decreased Appetite, Vomiting, Stomatitis, Pneumonia, Alanine Aminotransferase Increased, Lymphopenia, Anaemia, Febrile Neutropenia, Rash, Blood Phosphorus Decreased, Blood Potassium Decreased, Diarrhoea, Alopecia, Aspartate Aminotransferase Increased, Neutropenia, Leukopenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Adriamycin PFS
Dosage: 30 mg/m2 x 1/4 week
Start date: 2011-03-16
Adriamycin PFS
Dosage: 40 mg/m2 x 1/4 week
Indication: Adult T-Cell Lymphoma / Leukaemia
Start date: 2011-03-09
Carboplatin
Dosage: 250 mg/m2 x 1/4 week
Indication: Adult T-Cell Lymphoma / Leukaemia
Start date: 2011-03-24
Cyclophosphamide
Dosage: 350 mg/m2 x 1/4 week
Indication: Adult T-Cell Lymphoma / Leukaemia
Start date: 2011-03-09
Etoposide
Dosage: 100 mg/m2 x 1/4 week
Indication: Adult T-Cell Lymphoma / Leukaemia
Start date: 2011-03-24
Prednisolone
Dosage: 40 mg/m2 x 1/4 week
Administration route: Oral
Indication: Adult T-Cell Lymphoma / Leukaemia
Start date: 2011-03-09
Prednisolone
Dosage: 1mg/kg x 1/2 week
Start date: 2011-12-13
End date: 2011-12-14
Prednisolone
Dosage: 40 mg/m2 x 1/4 week
Administration route: Oral
Start date: 2011-03-16
Prednisolone
Dosage: 2 mg/m2, 1x/day
Administration route: Oral
Start date: 2011-03-24
Ranimustine
Dosage: 60 mg/m2 x 1/4 week
Indication: Adult T-Cell Lymphoma / Leukaemia
Start date: 2011-03-16
Vincristine Sulfate
Dosage: 1 mg/m2 x 1/4 week
Indication: Adult T-Cell Lymphoma / Leukaemia
Start date: 2011-03-09
Vindesine Sulfate
Dosage: 2.4 mg/m2 x 1/4 week
Indication: Adult T-Cell Lymphoma / Leukaemia
Start date: 2011-03-24
Other drugs received by patient: Mucosolvan; Lansoprazole; Sulfamethoxazole and Trimethoprim; Armodafinil; Zolpidem; Olopatadine HCL; Cefazolin Sodium; Ciprofloxacin HCL; Armodafinil; Zovirax; Magmitt; Alendronate Sodium
Possible Carboplatin side effects in male
Reported by a physician from France on 2012-08-24
Patient: male
Reactions: Dermatitis Acneiform, Renal Failure, Neoplasm Malignant, Dehydration, Purpura, Neutropenia, Thrombocytopenia
Adverse event resulted in: death
Drug(s) suspected as cause:
Carboplatin
Dosage: 200 df, unknown/d
Indication: non-Small Cell Lung Cancer
Start date: 2012-08-03
Erlotinib Hydrochloride
Dosage: 150 mg, uid/qd
Administration route: Oral
Indication: non-Small Cell Lung Cancer
Erlotinib Hydrochloride
Dosage: 150 mg, uid/qd
Administration route: Oral
Start date: 2012-08-17
Pemetrexed Disodium
Dosage: 200 df, unknown/d
Indication: non-Small Cell Lung Cancer
Start date: 2012-08-03
Possible Carboplatin side effects in male
Reported by a physician from Hungary on 2012-08-22
Patient: male, weighing 74.0 kg (162.8 pounds)
Reactions: Pneumonia, Anaemia, Granulocytopenia, Neutropenia, Thrombocytopenia, Leukopenia, Infectious Pleural Effusion
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Avastin
Dosage: frequency: 1x, form infusion;
Indication: non-Small Cell Lung Cancer
Avastin
Dosage: frequency as per protocol, last dose of prior to event on 25 january 2010. form infusion
Avastin
Dosage: last dose prior to sae: 16 february 2010. last dose prior to leukopenia was 23 mar 2010
Avastin
Dosage: last dose prior to sae: 16 february 2010,infusion, frequency: 1xdaily
Carboplatin
Dosage: last dose prior to event on 25 january 2010.
Carboplatin
Dosage: form: infusion;
Indication: non-Small Cell Lung Cancer
Carboplatin
Dosage: last dose prior to sae: 23 march 2010, frequency: 1xdaily
Carboplatin
Gemcitabine Hydrochloride
Dosage: last dose prior to sae: 01 april 2010
Gemcitabine Hydrochloride
Gemcitabine Hydrochloride
Dosage: freq: day 1 + 8 every 3 weeks
Gemcitabine Hydrochloride
Dosage: last dose of iv gemcitabine prior to event on 25 january 2010.
Gemcitabine Hydrochloride
Dosage: freq: day 1 + 8 every 3 weeks
Gemcitabine Hydrochloride
Dosage: form infusion, on day 1 and day 8; frequency: 1xdaily;
Indication: non-Small Cell Lung Cancer
Start date: 2009-11-09
End date: 2009-11-17
Gemcitabine Hydrochloride
Dosage: frequency: 2xevery three week, form: infusion
Other drugs received by patient: Fluticasone Propionate / Salmeterol; Augmentin '500'; Kalium-R; Sinecod; Ondansetron; Bisoprolol Fumarate; Pegfilgrastim; Lidocaine; Ciprofloxacin Hydrochloride; Neupogen; Spiriva; Kalium-R; Eprex; Neorecormon; Hydromorphone HCL; Berodual; Fluticasone Propionate / Salmeterol; Neorecormon; Augmentin '500'; Kalium-R; Medrol; Medrol; Neupogen; Medrol; Bisoprolol Fumarate; Spiriva; Megesin; Megesin
Possible Carboplatin side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-21
Patient:
Reactions: Off Label Use, Gastrointestinal Toxicity, Neutropenia, Infection
Drug(s) suspected as cause:
Carboplatin
Dosage: 6 courses in high risk
Indication: Retinoblastoma
Cyclophosphamide
Indication: Retinoblastoma
Doxorubicin HCL
Dosage: 4 courses in intermediate risk and 6 courses in high risk
Indication: Retinoblastoma
Etoposide
Indication: Retinoblastoma
Vincristine
Dosage: 4 courses in intermediate risk and 6 courses in high risk
Indication: Retinoblastoma
Other drugs received by patient: Neupogen
Possible Carboplatin side effects in
Reported by a individual with unspecified qualification from United States on 2012-08-21
Patient: , weighing 61.4 kg (135.1 pounds)
Reactions: Neutropenia, Enterocolitis
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Carboplatin
Dosage: 2150 mg
Start date: 2012-07-13
Cyclophosphamide
Dosage: 1000 mg
Start date: 2012-08-09
Doxorubicin Hydrochloride
Dosage: 100 mg
Start date: 2012-08-09
Taxol
Dosage: 1242 mg
Start date: 2012-08-03
Possible Carboplatin side effects in 65 year old female
Reported by a physician from Germany on 2012-08-20
Patient: 65 year old female, weighing 86.0 kg (189.2 pounds)
Reactions: Neutropenia
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Carboplatin
Dosage: dose reduced
Start date: 2010-06-15
End date: 2010-07-22
Carboplatin
Dosage: form: vialsdose level: 5 auc
Start date: 2010-05-04
Docetaxel
Dosage: dose: 60mg/m2, form:vials
Start date: 2010-05-04
Docetaxel
Dosage: dose reduced, form:vials
Start date: 2010-06-15
End date: 2010-07-22
Trastuzumab
Dosage: dose level: 6mg/kgform: vials
Start date: 2010-05-04
End date: 2010-07-22
Other drugs received by patient: Metoclopramide; Bisoprolol Fumarate; Ondansetron; Dexamethasone; Emend; Loperamide
Possible Carboplatin side effects in 77 year old male
Reported by a physician from United States on 2012-08-08
Patient: 77 year old male, weighing 66.6 kg (146.5 pounds)
Reactions: Pneumonia, Neutropenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Avastin
Dosage: date of last dos prior to sae: 13/feb/2012,
Indication: Neoplasm
Carboplatin
Dosage: last dose: 648 mg, date of last dos prior to sae:13/feb/2012, last dose: 03/apr/2012
Indication: Neoplasm
GDC-0980 (Pi3k / Mtor Inhibitor)
Dosage: last dose: 25 mg, date of last dose prior to sae 5/apr/2012
Administration route: Oral
Indication: Neoplasm
Paclitaxel
Dosage: last dose: 360 mg, date of last dose prior to sae: 13/feb/2012, last dose: 05/apr/2012
Indication: Neoplasm
Other drugs received by patient: Ondansetron; Naproxen (Aleve); Zantac; Milk OF Magnesia TAB; Acyclovir; Restoril; Imodium; Ondansetron; Plavix; Dicyclomine
Possible Carboplatin side effects in 65 year old female
Reported by a physician from Germany on 2012-08-01
Patient: 65 year old female, weighing 86.0 kg (189.2 pounds)
Reactions: Neutropenia
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Carboplatin
Dosage: form: vialsdose level: 5 auc
Start date: 2010-05-04
Carboplatin
Dosage: dose reduced
Start date: 2010-06-15
End date: 2010-07-22
Docetaxel
Dosage: dose: 60mg/m2
Start date: 2010-05-04
Docetaxel
Dosage: dose reduced
Start date: 2010-06-15
End date: 2010-07-22
Trastuzumab
Dosage: dose level: 6mg/kgform: vials
Start date: 2010-05-04
End date: 2010-07-22
Other drugs received by patient: Metoclopramide; Ondansetron; Emend; Bisoprolol Fumarate; Dexamethasone; Loperamide
Possible Carboplatin side effects in female
Reported by a physician from United States on 2012-08-01
Patient: female, weighing 136.5 kg (300.3 pounds)
Reactions: Neutropenia
Drug(s) suspected as cause:
Carboplatin
Dosage: 872 mg
Taxol
Dosage: 350 mg
Possible Carboplatin side effects in female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-31
Patient: female
Reactions: Hypophosphataemia, Fatigue, Tinnitus, Clostridium Difficile Colitis, Neutropenia, Thrombocytopenia, Klebsiella Bacteraemia
Drug(s) suspected as cause:
Carboplatin
Dosage: auc 7 reconstituted with one liter normal saline (day 1;repeated every 21 days),intraperitoneal
Indication: Ovarian Cancer
Carboplatin
Dosage: auc 7 reconstituted with one liter normal saline (day 1;repeated every 21 days),intraperitoneal
Indication: Malignant Peritoneal Neoplasm
Carboplatin
Dosage: auc 7 reconstituted with one liter normal saline (day 1;repeated every 21 days),intraperitoneal
Indication: Fallopian Tube Cancer
Paclitaxel
Dosage: 60 mg/m2 reconstituted with one liter normal saline (day 8; repeated every 21 days),intraperitoneal
Indication: Ovarian Cancer
Paclitaxel
Dosage: 60 mg/m2 reconstituted with one liter normal saline (day 8; repeated every 21 days),intraperitoneal
Indication: Fallopian Tube Cancer
Paclitaxel
Dosage: 175 mg/m2 (day 1;repeated every 21 days),intravenous
Indication: Fallopian Tube Cancer
Paclitaxel
Dosage: 175 mg/m2 (day 1;repeated every 21 days),intravenous
Indication: Ovarian Cancer
Possible Carboplatin side effects in male
Reported by a physician from United States on 2012-07-23
Patient: male, weighing 84.0 kg (184.8 pounds)
Reactions: White Blood Cell Count Decreased, Neutropenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Carboplatin
Dosage: 1293 mg
End date: 2011-02-10
Paclitaxel
Dosage: 760 mg
End date: 2011-02-10
Other drugs received by patient: ...
Possible Carboplatin side effects in male
Reported by a physician from United States on 2012-07-23
Patient: male, weighing 84.1 kg (185.0 pounds)
Reactions: White Blood Cell Count Decreased, Neutropenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Carboplatin
Dosage: 1294 mg
End date: 2010-12-30
Paclitaxel
Dosage: 760 mg
End date: 2010-12-30
Possible Carboplatin side effects in female
Reported by a physician from China on 2012-07-17
Patient: female, weighing 63.0 kg (138.6 pounds)
Reactions: Suicide Attempt, Neutropenia
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Avastin
Dosage: last dose: 21 jul 2010
Indication: Breast Cancer
Start date: 2010-03-16
End date: 2010-08-30
Carboplatin
Dosage: last dose: 30 jun 2010
Indication: Breast Cancer
Start date: 2010-03-16
Clonazepam
Indication: Product Used FOR Unknown Indication
Docetaxel
Dosage: last dose: 30 jun 2010
Indication: Breast Cancer
Start date: 2010-03-16
Herceptin
Dosage: last dose: 21 jul 2010
Indication: Breast Cancer
Start date: 2010-03-16
End date: 2010-08-30
Possible Carboplatin side effects in 58 year old male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-17
Patient: 58 year old male, weighing 58.0 kg (127.6 pounds)
Reactions: Oropharyngeal Pain, Neutropenia, Radiation Mucositis
Adverse event resulted in: life threatening event, hospitalization, disablity
Drug(s) suspected as cause:
Carboplatin
Dosage: 1df auc =5, dose redused to auc 3.
Indication: non-Small Cell Lung Cancer
Start date: 2012-06-04
Gemcitabine Hydrochloride
Dosage: last dose on:11jun12 dose redused to:500mg/m2
Indication: non-Small Cell Lung Cancer
Start date: 2012-06-04
Ramucirumab
Indication: non-Small Cell Lung Cancer
Start date: 2012-06-04
Other drugs received by patient: Prilosec; Ondansetron; Neupogen; Methadone HCL; Levaquin; Roxanol; Zometa; Promethazine; Warfarin Sodium; Platelets
Possible Carboplatin side effects in 76 year old male
Reported by a health professional (non-physician/pharmacist) from Japan on 2012-07-17
Patient: 76 year old male, weighing 70.0 kg (154.0 pounds)
Reactions: Hypotension, Disseminated Intravascular Coagulation, Headache, Malaise, Sepsis, Neutropenia, Cardiac Arrest, Thrombocytopenia
Adverse event resulted in: death
Drug(s) suspected as cause:
Carboplatin
Dosage: dose unit: unknown
Indication: Small Cell Lung Cancer Stage Unspecified
Start date: 2010-10-04
End date: 2010-10-04
Etoposide
Dosage: dose unit: unknown
Indication: Small Cell Lung Cancer Stage Unspecified
Start date: 2010-10-04
End date: 2010-10-06
Other drugs received by patient: Aldactone; Urief; Warfarin Sodium; Alendronate Sodium; Spiriva; Magnesium Oxide; Theophylline; Ambroxol Hydrochloride; Enalapril Maleate; Seltepnon; Vasolator; Sotalol Hydrochloride
Possible Carboplatin side effects in 64 year old female
Reported by a physician from France on 2012-07-16
Patient: 64 year old female, weighing 54.0 kg (118.8 pounds)
Reactions: Muscle Atrophy, Neutropenia, Polyarthritis, Thrombocytopenia, Paraesthesia
Drug(s) suspected as cause:
Carboplatin
Indication: Bronchial Carcinoma
End date: 2011-06-01
Taxotere
Dosage: dose: 4 cycles at 120 mg every 3 weeks
Indication: Bronchial Carcinoma
Start date: 2011-03-28
End date: 2011-06-03
Possible Carboplatin side effects in 59 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-13
Patient: 59 year old female, weighing 58.9 kg (129.6 pounds)
Reactions: Otitis Externa, Skin Hyperpigmentation, Hypoacusis, Neuropathy Peripheral, Diarrhoea, Ear Pain, Otitis Media, Neutropenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Abraxane
Dosage: 128 mg iv, 118 mg iv
Indication: Chemotherapy
Start date: 2012-04-17
End date: 2012-06-26
Carboplatin
Dosage: 720 mg
Indication: Chemotherapy
Start date: 2012-04-17
End date: 2012-06-26
Other drugs received by patient: Zofren 8 MG; Atenolol; Neurontin
Possible Carboplatin side effects in male
Reported by a health professional (non-physician/pharmacist) from Italy on 2012-07-13
Patient: male
Reactions: Liver Function Test Abnormal, Neutropenia, Thrombocytopenia, Haemolysis
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Carboplatin
Possible Carboplatin side effects in male
Reported by a physician from Japan on 2012-07-12
Patient: male, weighing 57.0 kg (125.4 pounds)
Reactions: Pneumonia, Nasopharyngitis, Rash, Eczema, Pruritus Generalised, Colonic Polyp, Interstitial Lung Disease, Insomnia, Bone Marrow Failure, Neutropenia, Neutrophil Count Decreased, Hypertension
Adverse event resulted in: death
Drug(s) suspected as cause:
Avastin
Start date: 2012-03-15
End date: 2012-03-15
Avastin
Start date: 2012-02-01
End date: 2012-02-01
Avastin
Indication: Lung Adenocarcinoma Metastatic
Start date: 2011-12-28
End date: 2011-12-28
Carboplatin
Start date: 2012-03-15
End date: 2012-03-15
Carboplatin
Indication: Lung Adenocarcinoma Metastatic
Start date: 2012-02-01
End date: 2012-02-01
Paclitaxel
Indication: Lung Adenocarcinoma Metastatic
Start date: 2012-03-15
End date: 2012-04-12
Sulbacilline
Indication: Interstitial Lung Disease
Start date: 2012-05-02
End date: 2012-05-09
Other drugs received by patient: Loxoprofen; Famotidine; Dexamethasone Sodium Phosphate; Restamin; Granisetron; Diclofenac Sodium; Sennoside; Vitamedin; Rebamipide; Zofran
Possible Carboplatin side effects in male
Reported by a physician from Italy on 2012-07-11
Patient: male
Reactions: Liver Function Test Abnormal, Neutropenia, Thrombocytopenia, Haemolysis
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Carboplatin
Possible Carboplatin side effects in male
Reported by a physician from United States on 2012-07-10
Patient: male, weighing 84.1 kg (185.0 pounds)
Reactions: White Blood Cell Count Decreased, Neutropenia
Drug(s) suspected as cause:
Carboplatin
Dosage: 1292 mg
End date: 2011-02-10
Erbitux
Dosage: 2880 mg
End date: 2011-02-24
Paclitaxel
Dosage: 760 mg
End date: 2011-02-10
Possible Carboplatin side effects in female
Reported by a individual with unspecified qualification from United States on 2012-07-09
Patient: female, weighing 136.5 kg (300.3 pounds)
Reactions: Neutropenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Carboplatin
Dosage: 872 mg
Paclitaxel
Dosage: 350 mg
Possible Carboplatin side effects in 72 year old female
Reported by a physician from Israel on 2012-07-06
Patient: 72 year old female, weighing 55.0 kg (121.0 pounds)
Reactions: Multi-Organ Failure, Urosepsis, Blood Pressure Abnormal, Neutropenia, Myocardial Infarction, Heart Rate Abnormal, Cerebral Haemorrhage
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Bevacizumab
Bevacizumab
Dosage: total dose 828 mg
Start date: 2010-07-28
End date: 2010-07-28
Bevacizumab
Dosage: total dose 828 mg
Start date: 2010-10-25
End date: 2010-10-25
Carboplatin
Dosage: form: vialdose level: 5 auc
Start date: 2010-10-25
End date: 2010-10-25
Carboplatin
Dosage: form: vialdose level: 5 auc
Start date: 2010-07-28
End date: 2010-07-28
Carboplatin
Docetaxel
Dosage: form: vialdose level: 75 mg/m2
Start date: 2010-10-25
End date: 2010-10-25
Docetaxel
Dosage: form: vialdose level: 75 mg/m2
Start date: 2010-07-28
End date: 2010-07-28
Docetaxel
Trastuzumab
Start date: 2010-07-28
End date: 2010-07-28
Trastuzumab
Dosage: dose level:6 mg/kg
Start date: 2010-10-25
End date: 2010-10-25
Trastuzumab
Other drugs received by patient: Omeprazole; Bondormin; Micropirin; Simvastatin; Citalopram Hydrobromide; Ramipril; Disothiazide
Possible Carboplatin side effects in male
Reported by a physician from United States on 2012-07-05
Patient: male, weighing 64.7 kg (142.3 pounds)
Reactions: Radiation Mucositis, Neutropenia, Oropharyngeal Pain
Adverse event resulted in: life threatening event, hospitalization, disablity
Drug(s) suspected as cause:
Carboplatin
Dosage: unk, other
Indication: non-Small Cell Lung Cancer
Start date: 2012-06-04
End date: 2012-06-04
Carboplatin
Dosage: 3 df, other
Gemcitabine Hydrochloride
Dosage: 500 mg/m2, other
Gemcitabine Hydrochloride
Dosage: 1000 mg/m2, other
Indication: non-Small Cell Lung Cancer
Start date: 2012-06-04
End date: 2012-06-11
Ramucirumab (1121b) (Ly3009806)
Dosage: 10 mg/kg, other
Indication: non-Small Cell Lung Cancer
Start date: 2012-06-04
Other drugs received by patient: Ondansetron; Levaquin; Prilosec; Roxanol; Promethazine; Zometa; Hydrocodone Bitartrate; Warfarin Sodium; Methadon HCL TAB; Platelets; Neupogen; Promethazine
Possible Carboplatin side effects in 32 year old male
Reported by a consumer/non-health professional from Italy on 2012-06-28
Patient: 32 year old male
Reactions: Vomiting, Alopecia, Neutropenia, Asthenia
Drug(s) suspected as cause:
Bleomycin Sulfate
Indication: Testicular Seminoma (Pure)
Start date: 2011-09-16
End date: 2011-12-10
Carboplatin
Indication: Testis Cancer
Start date: 2011-09-23
End date: 2011-12-10
Cisplatin
Indication: Testicular Seminoma (Pure)
Start date: 2011-09-16
End date: 2011-12-10
Vepesid
Indication: Testicular Seminoma (Pure)
Start date: 2011-09-16
End date: 2011-12-10
Possible Carboplatin side effects in female
Reported by a consumer/non-health professional from Italy on 2012-06-27
Patient: female
Reactions: Respiratory Failure, Neutropenia, Thrombocytopenia, Decreased Appetite
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Carboplatin
Possible Carboplatin side effects in 65 year old female
Reported by a physician from Germany on 2012-06-20
Patient: 65 year old female, weighing 86.0 kg (189.2 pounds)
Reactions: Neutropenia
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Carboplatin
Dosage: form: vialsdose level: 5 auc
Start date: 2010-05-04
Carboplatin
Dosage: dose reduced
Start date: 2010-06-15
End date: 2010-07-22
Docetaxel
Dosage: dose: 60mg/m2
Start date: 2010-05-04
Docetaxel
Dosage: dose reduced
Start date: 2010-06-15
End date: 2010-07-22
Trastuzumab
Dosage: dose level: 6mg/kgform: vials
Start date: 2010-05-04
End date: 2010-07-22
Other drugs received by patient: Metoclopramide; Bisoprolol Fumarate; Emend; Dexamethasone; Ondansetron; Loperamide
Possible Carboplatin side effects in
Reported by a individual with unspecified qualification from United States on 2012-06-18
Patient:
Reactions: Thrombosis, Confusional State, Pain, Fatigue, Thrombocytopenia, Decreased Appetite, Arterial Thrombosis, Vomiting, Dyspnoea, Nausea, Lymphopenia, Anaemia, Hyponatraemia, Pulmonary Haemorrhage, Diarrhoea, Dehydration, Neutropenia, Hypertension, Infection
Drug(s) suspected as cause:
Avastin
Indication: non-Small Cell Lung Cancer
Bortezomib and Bortezomib
Dosage: 1.3, 1.6 and 1.8 mg/square meter weekly on day 1 and day 8 of every 3 week cycle
Indication: non-Small Cell Lung Cancer
Carboplatin
Dosage: auc 6
Indication: non-Small Cell Lung Cancer
Page 1 Next >>
|
